Results 51 to 60 of about 143,834 (302)

Acinetobacter infections: Overview and treatment dilemma

CHRISMED Journal of Health and Research, 2020
Introduction: Acinetobacter species are known to cause serious hospital-acquired infections (HAIs), especially in the intensive care unit (ICU). The aim of this study is to estimate the burden of such infections and also to determine their sensitivity to
Sana Ali
doaj   +1 more source

Acinetobacter baumannii: an evolving and cunning opponent

Frontiers in Microbiology
Acinetobacter baumannii is one of the most common multidrug-resistant pathogens causing nosocomial infections. The prevalence of multidrug-resistant A. baumannii infections is increasing because of several factors, including unregulated antibiotic use. A.
Jingchao Shi, Jianghao Cheng, Shourong Liu, Yufeng Zhu, Mingli Zhu   +4 more
semanticscholar   +1 more source

Update on Multidrug Resistance Efflux Pumps in Acinetobacter spp.

Antimicrobial Agents and Chemotherapy, 2021
Acinetobacter spp. have become of increased clinical importance as studies have shown the antimicrobial resistant potential of these species. Efflux pumps can lead to reduced susceptibility to a variety of antibiotics and are present in large number ...
Vanessa Kornelsen, Ayush Kumar
semanticscholar   +1 more source

Epidemiology of Biofilm Producing Acinetobacter baumannii Nosocomial Isolates from a Tertiary Care Hospital in Egypt: A Cross-Sectional Study

Infection and Drug Resistance, 2021
Ahmed Morad Asaad,1 Shamshul Ansari,2 Soma Elsayed Ajlan,3 Samah Mohammed Awad4 1Department of Medical Microbiology and Immunology, Faculty of Medicine, Zagazig University, Zagazig, Egypt; 2Department of Microbiology and Immunology, Chitwan Medical ...
Asaad AM, Ansari S, Ajlan SE, Awad SM
doaj  

Prevalence and antibiotic resistance patterns of nosocomial urinary tract infections in ICU patients at Shahid Beheshti hospital, Kashan, Iran (2020–2021) [PDF]

Basic and Clinical Biochemistry and Nutrition
Background: Nosocomial urinary tract infections (UTIs) are a significant cause of morbidity and mortality in intensive care units (ICUs), particularly due to the increasing prevalence of multidrug-resistant (MDR) pathogens.
Mohanna Pourjozi, Mahdi Imani, Hamed Pahlevani, Habibollah Rahimi, Maedeh Najafizadeh   +4 more
doaj   +1 more source

Defining Resistance in Acinetobacter calcoaceticus-Acinetobacter baumannii Complex Strains [PDF]

Antimicrobial Agents and Chemotherapy, 2013
We read with great interest the recent publication of Tien and colleagues in which they describe the antimicrobial susceptibilities of a large number of Acinetobacter baumannii-Acinetobacter calcoaceticus strains isolated from a medical center in Taiwan ([1][1]).
Carlos Henrique, Camargo, Ariane, Bruder-Nascimento   +1 more
openaire   +2 more sources

Evaluating Cefiderocol in the Treatment of Multidrug-Resistant Gram-Negative Bacilli: A Review of the Emerging Data

Infection and Drug Resistance, 2020
Daniele Roberto Giacobbe,1,2 Eugenio Ciacco,3 Corrado Girmenia,4 Federico Pea,5,6 Gian Maria Rossolini,7,8 Giovanni Sotgiu,9 Carlo Tascini,10 Mario Tumbarello,11,12 Pierluigi Viale,5,6 Matteo Bassetti1,2 On behalf of the ISGRI-SITA (Italian Study Group ...
Giacobbe DR, Ciacco E, Girmenia C, Pea F, Rossolini GM, Sotgiu G, Tascini C, Tumbarello M, Viale P, Bassetti M   +9 more
doaj  

Taxonomy of the Genus Acinetobacter with the Recognition of Acinetobacter baumannii sp. nov., Acinetobacter haemolyticus sp. nov., Acinetobacter johnsonii sp. nov., and Acinetobacter junii sp. nov. and Emended Descriptions of Acinetobacter calcoaceticus and Acinetobacter lwoffii [PDF]

International Journal of Systematic Bacteriology, 1986
Using deoxyribonucleic acid hybridization (S1 nuclease method), we identified 12 hybridization groups (genospecies) containing 74 strains among 85 Acinetobacter strains studied. A total of 28 characters which allowed identification of the genospecies were applied to 266 strains. Of the 12 genospecies, 11 could be unambiguously identified. Genospecies 1
P. J. M. Bouvet, P. A. D. Grimont
openaire   +1 more source

Antibiofilm activity of a chionodracine‐derived peptide by NMR‐based metabolomics of cell‐free supernatant of Acinetobacter baumannii clinical strains

FEBS Open Bio, EarlyView.
KHS‐Cnd peptide is able to impair biofilm formation and disaggregate mature biofilms in Acinetobacter baumannii clinical isolates. Differences in extracellular metabolites reflect changes in biofilm metabolism due to KHS‐Cnd treatment. Among the differentially represented extracellular metabolites upon KHS‐Cnd treatment, the significantly altered ...
Fernando Porcelli, Enrico Landi, Francesco Maiurano, Irene Paris, Rosanna Papa, Marco Artini, Laura Selan, Stefano Borocci, Francesco Buonocore, Esther Imperlini   +9 more
wiley   +1 more source

High-dose Sulbactam Treatment for Ventilator-Associated Pneumonia Caused by Carbapenem-Resistant [PDF]

Korean Journal of Critical Care Medicine, 2016
Background Several antibiotics can be used to treat ventilator-associated pneumonia caused by carbapenem-resistant A. baumannii (CRAB-VAP) including high-dose sulbactam. However, the effectiveness of high-dose sulbactam therapy is not well known.
In Beom Jeong, Moon Jun Na, Ji Woong Son, Do Yeon Jo, Sun Jung Kwon   +4 more
doaj   +1 more source